Vitruvias Therapeutics drugs

6 results
  • bupropion hydrochloride

    (Bupropion hydrochloride)
    Vitruvias Therapeutics
    Bupropion hydrochloride extended-release tablets are indicated for the treatment of major depressive disorder (MDD) and the prevention of seasonal major depressive episodes in patients with seasonal affective disorder (SAD). Efficacy was established through controlled trials for both conditions.
  • propafenone hydrochloride

    (propafenone)
    Vitruvias Therapeutics
    Propafenone hydrochloride extended-release capsules are indicated for prolonging the time to recurrence of symptomatic atrial fibrillation (AF) in patients with episodic AF who lack structural heart disease. Its use is not established for permanent AF or atrial flutter, nor for controlling ventricular rate during AF.